Support Our Work

Please donate so we can continue our work to reduce the stigma of psychiatric illness, encourage research, and support educational activities for behavioral health professionals and the public. Ways you can donate and help are on our Support and Donations page. Thank you!

More Info

Latest News Around the Web

Gun Violence In US Likely Driven By High Number Of Available Firearms, Study Suggests

HealthDay (12/12, Thompson) reports “gun advocates often claim that mental illness is the driving force behind mass shootings in the United States,” but a new study “argues that gun violence is more likely driven by the massive numbers of firearms available throughout the country, providing easy access.” The findingswere published in the American Journal of Medicine.

Related Links:

— “Firearm Access Drives High Rate of U.S. Gun Deaths, International Study Finds,” Dennis Thompson, HealthDay, December 12, 2023

Isotretinoin (Accutane) Not Linked To Increased Risk For Suicide Or Psychiatric Conditions, Study Suggests

Healio (12/12, Capaldo) reports, “Isotretinoin is not associated with an increased risk for suicide or psychiatric conditions on a population level, according to a study.” The researchers found “isotretinoin use was associated with a lower risk of suicide attempt at 2 to 4 years following treatment.” The findings were published in JAMA Dermatology.

Related Links:

— “Isotretinoin not associated with increased risk for suicide, psychiatric conditions,” Gabrielle Capaldo, Healio, December 12, 2023

Cannabis-Based Medicinal Products Linked To Improving Anxiety, Quality Of Life In Patients With AD/HD, Study Suggests

HCPlive (12/11, Derman) reports, “Cannabis-based medicinal products (CBMPs) are associated with improving anxiety, sleep quality, and health-related quality of life in patients with” AD/HD, “according to a new study.” The research found that “with the CBMP treatment, less patients had to take concomitant” AD/HD “medication, with a reduction of 38.46% in lisdexamfetamine, 15% in methylphenidate, and 14.29% in dexamfetamine.” The findings were published in Neuropsychopharmacology Reports.

Related Links:

— “Cannabis Treatment Linked to Improving Quality of Life in ADHD Patients,” Chelsie Derman, HCPLive, December 11, 2023

Study Connects Increase In Child Suicides To US Opioid Crisis

Healio (12/11, Weldon) reports, “A rise in child suicides in the United States may be connected to the nation’s opioid crisis, according to a study.” The research “found 48,063 deaths designated as suicides for the 10- to 17-year-old population in the U.S. from 1980 to 2020.” According to the “study, areas of the U.S. that had more exposure to reformulated OxyContin [oxycodone hydrochloride] ‘experienced sharper growth in child suicide rates.’” The findings were published in Demography.

Related Links:

— “Study links ‘shocking’ rise in child suicide rates to opioid crisis,” Rose Weldon, Healio, December 11, 2023

Study Connects Increase In Child Suicides To US Opioid Crisis

Healio (12/11, Weldon) reports, “A rise in child suicides in the United States may be connected to the nation’s opioid crisis, according to a study.” The research “found 48,063 deaths designated as suicides for the 10- to 17-year-old population in the U.S. from 1980 to 2020.” According to the “study, areas of the U.S. that had more exposure to reformulated OxyContin [oxycodone hydrochloride] ‘experienced sharper growth in child suicide rates.’” The findings were published in Demography.

Related Links:

— “Study links ‘shocking’ rise in child suicide rates to opioid crisis,” Rose Weldon, Healio, December 11, 2023

Foundation News

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.